Fortelizin in bridging therapy of acute ischemic stroke: data from the observational study FORPI registry

Key Points

• To evaluate the safety and efficacy of Fortelizin in the treatment of acute ischemic stroke during real-world application.
• Observational study design using data from the FORPI registry.
• Focus on patients receiving Fortelizin as bridging therapy.
• Assessment of clinical outcomes related to safety and efficacy.
• Fortelizin demonstrated a favorable safety profile.
• Efficacy observed in improving outcomes for acute ischemic stroke patients.